EUVIMEDEUVIMED entdecken
Crossref

Evolution in the Management of Left-Sided Obstructive Colon Cancer in the Netherlands During a 9-Year Period

Julie M L Sijmons, Jan Willem T Dekker, Jurriaan B Tuynman, Femke J Amelung, Esther C J Consten, Henderik L van Westreenen, Johannes H W de Wilt, Rob A E M Tollenaar, Pieter J Tanis

Journal of the National Comprehensive Cancer Network · 2024

DOI: 10.6004/jnccn.2024.7057 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2024. Verfasst von Julie M L Sijmons und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Colonic Neoplasms, Intestinal Obstruction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There is growing evidence that bridge to surgery with stent or decompressing stoma for left-sided obstructive colon cancer (LSOCC) is better than emergency resection (ER), especially in elderly patients (age ≥70 years). This was already incorporated in Dutch guideline recommendations in 2014. The aim of this study was to evaluate time trends and interhospital variability in treatment approaches for LSOCC, and to compare short-term outcomes between approaches. Patients and Methods: Data of patients undergoing resection for LSOCC between 2012 and 2020 were extracted from the Dutch ColoRectal Audit.

Results

A total of 4,535 patients were included (3,155 ER, 573 semielective resection [SER], 807 resection after stent or stoma [RSS]). A decrease in ER over time was observed (79.7% in 2012–2014, 68.8% in 2015–2017, and 54.7% in 2018–2020) in favor of RSS (9.2%, 17.9%, and 31.2%, respectively). Compared with SER and RSS, ER was associated with higher 30-day mortality (6.2% ER, 2.8% SER, and 1.0% RSS; P 75% ER, mortality was significantly higher compared with hospitals mainly performing SER and RSS (5.6% vs 4.2%; P =.038). The proportion of ER in patients (age ≥70 years) decreased from 80.7% in 2012–2014 to 54.3% in 2018–2020 ( P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colonic NeoplasmsIntestinal ObstructionHumansAgedNetherlandsFemaleMaleAged, 80 and overMiddle AgedTreatment OutcomeStents

Autor:innen und Institutionen

  • Department of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Dutch Institute for Clinical Auditing, Leiden, the Netherlands.
  • Cancer Treatment and Quality of Life, Cancer Center Amsterdam, Amsterdam, the Netherlands.
  • Department of Surgery, Reinier de Graaf Groep, Delft, the Netherlands.
  • Department of Surgery, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
  • Department of Surgery, Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, the Netherlands.

Zitieren

APA

Sijmons, J. M. L., Dekker, J. W. T., Tuynman, J. B., Amelung, F. J., Consten, E. C. J., van Westreenen, H. L., de Wilt, J. H. W., Tollenaar, R. A. E. M., & Tanis, P. J. (2024). Evolution in the Management of Left-Sided Obstructive Colon Cancer in the Netherlands During a 9-Year Period. Journal of the National Comprehensive Cancer Network. https://doi.org/10.6004/jnccn.2024.7057

Vancouver

Sijmons JML, Dekker JWT, Tuynman JB, Amelung FJ, Consten ECJ, van Westreenen HL, et al. Evolution in the Management of Left-Sided Obstructive Colon Cancer in the Netherlands During a 9-Year Period. Journal of the National Comprehensive Cancer Network. 2024. doi:10.6004/jnccn.2024.7057

BibTeX
@article{Sijmons2024,
  author = {Sijmons, Julie M L and Dekker, Jan Willem T and Tuynman, Jurriaan B and Amelung, Femke J and Consten, Esther C J and van Westreenen, Henderik L and de Wilt, Johannes H W and Tollenaar, Rob A E M and Tanis, Pieter J},
  title = {Evolution in the Management of Left-Sided Obstructive Colon Cancer in the Netherlands During a 9-Year Period},
  journal = {Journal of the National Comprehensive Cancer Network},
  year = {2024},
  doi = {10.6004/jnccn.2024.7057}
}
Kostenlos starten →